• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic research for clinical application of a novel FLT3 inhibitor and development of a model mouse for the evaluation of anti-leukemia cell effect.

Research Project

Project/Area Number 16590932
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNagoya University

Principal Investigator

KIYOI Hitoshi  Nagoya Univ., University Hospital, Assistant Professor, 医学部附属病院, 講師 (90314004)

Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2005: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2004: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsFLT3 / Leukemia / Molecular target therapy / Tyrosinekinase / Inhibitor
Research Abstract

We have developed a novel FLT3 kinase inhibitor by using a high-throughput screening. This inhibitor shows the selective growth inhibition against human leukemia cell-lines harboring FLT3 gene mutations, and of which IC_<50> is around 10 nM. The purpose of this study is confirming the proof of principle (POP) of this inhibitor for applying clinical use.
1. We first established the mutant FLT3-associated leukemia mouse model by inoculating mutant FLT3-expressing 32D cells into syngeneic C3H mice. These mice developed leukemia within a week after the inoculation of mutant FLT3-expressing 32D cells, then died within 2 weeks. However, when these mice were treated with the novel inhibitor for 2weeks from the 10th day after the inoculation, all mice revealed the cure from leukemia, confirming the POP of this inhibitor.
2. We next compared the effects on leukemia regression and normal haematopoiesis between the novel inhibitor and Ara-C. The administration of Ara-C could not only inhibit the leukemia cell growth but also induced severe BM suppression, while the novel inhibitor achieved leukemia cell regression without BM suppression.
3. These results indicated that the novel FLT3 inhibitor could bring the cure to the leukemia mice, while the appropriate surrogate marker, which can predict the effectiveness of the inhibitor in clinical use, is required. Since STAT5 is constitutively activated in the mutant FLT3-expressing cells, phospho-STAT5 is thought to be a candidate of the surrogate marker. We have developed a monoclonal antibody against phospho-STAT5, which can be used both in the western blotting and flow cytometry. By using this antibody, we demonstrated that the reduction level of phospho-STAT5 status, which was quantitated by FCM analysis, is associated with the growth inhibition of leukemia cells.

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • Research Products

    (20 results)

All 2006 2005 2004

All Journal Article (20 results)

  • [Journal Article] Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemia.2006

    • Author(s)
      Sivasundaram Karnan
    • Journal Title

      Genes Chromosomes Cancer 46

      Pages: 187-197

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemia.2006

    • Author(s)
      Sivasundaram Kaman
    • Journal Title

      Genes Chromosomes Cancer 46

      Pages: 187-197

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.2005

    • Author(s)
      Tatsuya Suzuki
    • Journal Title

      Blood 106

      Pages: 2854-2861

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Clinical significance of FLT3 in leukemia.2005

    • Author(s)
      Hitoshi Kiyoi
    • Journal Title

      Int J Hematol 82

      Pages: 85-92

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] BMI-1 Is Highly Expressed in MO-Subtype Acute Myeloid Leukemia.2005

    • Author(s)
      Masashi Sawa
    • Journal Title

      Int J Hematol 82

      Pages: 42-47

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia : a meta-analysis.2005

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Leukemia 19

      Pages: 1345-1349

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.2005

    • Author(s)
      Masanori Iwai
    • Journal Title

      Leukemia 19

      Pages: 1367-1375

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification : a single-center experience.2005

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Eur J Haematol 74

      Pages: 418-423

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World, Health Organization classification : a single-center experience.2005

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Eur J Haematol 74

      Pages: 418-423

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia.2005

    • Author(s)
      Masashi Sawa
    • Journal Title

      Int J Hematol 82

      Pages: 42-47

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Normal and oncogenic FLT32004

    • Author(s)
      Tomaki Naoe
    • Journal Title

      Cell Mol Life Sci 61

      Pages: 2932-2938

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Multiplex real-time RT-PCR for prospective evaluation of WTI and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia.2004

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Leuk Lymphoma 45

      Pages: 1803-1808

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line.2004

    • Author(s)
      Manabu Ninomiya
    • Journal Title

      Leukemia 18

      Pages: 442-448

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia.2004

    • Author(s)
      Kazutaka Ozeki
    • Journal Title

      Blood 103

      Pages: 1901-1908

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Normal and oncogenic FLT3.2004

    • Author(s)
      Tomoki Naoe
    • Journal Title

      Cell Mol Life Sci 61

      Pages: 2932-2938

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia.2004

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Leuk Lymphoma 45

      Pages: 1803-1808

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Normal and oncogenic FLT32004

    • Author(s)
      Tomoki Naoe
    • Journal Title

      Cell Mol Life Sci 61

      Pages: 2932-2938

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia2004

    • Author(s)
      Masamitsu Yanada
    • Journal Title

      Leuk Lymphoma 45

      Pages: 1803-1808

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line2004

    • Author(s)
      Manabu Ninomiya
    • Journal Title

      Leukemia 18

      Pages: 442-448

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia2004

    • Author(s)
      Kazutaka Ozeki
    • Journal Title

      Blood 103

      Pages: 1901-1908

    • Related Report
      2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi